baber/WOPTO huggingface dataset:
Patent JP-2001525694-A (JP)
IPC: C09D5/14
Filed: 1998-05-04
Abstract: Disclosed are coatings and materials that resist bacterial colonization and encrustation for use in medical devices and urological applications. The coating includes acidic chelating components, reactively bound to a hydrophilic polyurethane prepolymer along with noble metal combinations or antibacterials. The acidic and noble metal combinations can also be incorporated as additives during plastic molding of medical devices. A continuous antibacterial surfaces are provided by such coatings and materials.
Patent JP-2000511275-A (JP)
Title: 容器冷却ジャケット及び予冷サービスシステム
IPC: F28D1/06
Filed: 1998-05-14
Abstract: (57)【要約】
液体の容器（１８）に使用する冷却ジャケット（１２）とサービスシステムであって、冷却ジャケット（１２）は容器（１８）の周囲にフィットするように提供された断熱材製のフレキシブルなシート材を含んでいる。このシート材はシート材の内側に蛇行形態で提供された冷却コイル管（５２）を、容器（１８）の側壁と直接的あるいは間接的に接触するように有している。この冷却コイル管（５２）は液体サービス構造体によって供給され、その構造体に再循環される冷却液バス（２４）に連通されている。
Patent JP-2001526571-A (JP)
IPC: B28D5/00
Filed: 1998-05-22
Abstract: An invisible information mark is provided on a facet of a diamond gemstone by applying a plasma resist to the exposed surface of the gemstone, applying an electrically conducting layer of metal to the region where the information mark is to be formed, ablating a selected zone of the metal and resist layers by ultraviolet laser thus forming a mask on the surface of the facet, electrically connecting the metal layer and plasma etching the facet through the mask, thus forming a mark of appropriate depth on the surface of the gemstone.
Patent JP-H1112576-A (JP)
Title: Meso phase pitch containing organometallic compound for spinning pitch carbon fiber
Inventor: ROMINE H ERNEST
IPC: C10C3/10
Filed: 1991-12-12
Abstract: PURPOSE: To provide a new method for producing a unique metal-containing isotropic pitch material that is suitable for production of carbon fiber. CONSTITUTION: A soluble aromatic organometallic compound is added to a carbon starting material that is substantially defective in the meso phase pitch, the resultant mixture is subjected to the heat soaking to give the isotropic pitch containing mesogen and soluble organometallic compound. Then, the pitch products are subjected to the solvent separation to separate the mesodiene containing the metal from the organometallic compound. This metal-containing mesogen is heated up to sufficiently elevated temperature and fused to form the metal-containing mesophase pitch. In another process, the carbon starting material is thermally soaked to form isotropic pitch product containing mesogen. A high-molecular-weight soluble aromatic organometallic compound is added to the mesogen-containing isotropic pitch product, then subjected to the solvent separation.  The metal-containing carbon fiber produced from the mesophase pitch shows increased stability and tensile strength. Alternatively, the solvent fractionation or separation is carried out under supercritical conditions to form metal-containing mesophase pitch. The formulation of the organometallic compound to the carbon source may be done either of before or after thermal soaking.
Patent MX-157017-A (MX)
Inventor: BATTGELLI JEAN
IPC: D04H1/00
Filed: 1982-08-02
Abstract: The invention relates to the distribution on a receiving device of fibers carried by a gas current. To improve the distribution, the gas current carrying the fibers is subjected to the action of a gas layer which envelopes the current and of which the direction of flow in a plane tangent to the gas current differs from that of the gas current. The action of the gas layer results in an expansion of the current carrying the fibers. The invention is particularly useful where the fibers are received on a collecting device such as a foraminous conveyor belt, of large width.
Patent MX-162402-A (MX)
Inventor: PARTRIDGE RANDALL DAVID
IPC: C10G47/18
Filed: 1983-05-18
Abstract: A hydrocracking process in which improved selectivity for the production of distillate range (165 DEG C - 343 DEG C) products is obtained by the use of a catalyst containing a highly siliceous large pore zeolite as the acidic component. Suitable zeolites include zeolites Y, ZSM-20 and beta with structural silica: alumina ratios of at least 50:1. The invention also provides such catalysts.
Patent MX-158862-A (MX)
Inventor: GEARY DAVID F
IPC: F28F9/22
Filed: 1984-02-27
Abstract: The invention comprises a high performance segmented baffled shell and tube heat exchanger (1) in which baffles (4, 5, 6 and 7) are oriented at angles less than 180 DEG  adjacent one another.
Patent NZ-204346-A (NZ)
Title: Iodophor compositions and use in bovine mastitis control
Inventor: WILSON E S
IPC: A61K9/22
Filed: 1983-05-24
Abstract: An iodophor composition comprising a complex of iodine with a quaternary ammonium compound of the general formula I: <CHEM> wherein L represents an acyl radical derived from lanolin fatty acid. R1 is hydrogen or a C1-4 alkyl group, R2 and R3 each represent a C1-4 alkyl group, R4 is an alkyl, aralkyl, hydroxyalkyl, or unsaturated aliphatic hydrocarbon radical, X is a compatible anion and n is an integer of from 2 to 5, in an aqueous medium, a method for its preparation and a method of disinfecting a locus employing said iodopher composition. The iodopher compositions are particularly suitable for use as teat or udder dips for the prevention or control of bovine mastitis.
Patent NZ-205228-A (NZ)
Title: Process for isolating amine adducts of microbial polysaccharides
Inventor: FISCHER E
IPC: C08B37/00
Filed: 1983-08-12
Abstract: Microbial polysaccharides can be quantitatively precipitated from their aqueous solutions, in particular directly from the fermentation solutions, in an acidic medium in the form of an adduct with a tertiary amine which has a long-chain alkyl radical. It is advantageous to add the amine to the polysaccharide solution and then to carry out the precipitation, in particular by adding the dispersion obtained to an acidic coagulation bath. The adducts are suitable for use as thickeners and for preparing the free polysaccharides.
Patent NZ-209657-A (NZ)
Title: Genetically engineered plant having the gene for a proteinacious insecticidal crystal
Inventor: ADANG M A
IPC: C12N15/05
Filed: 1984-09-24
Abstract: A method for introducing expressible insecticidal protein structural genes into plant genomes is provided. In the preferred embodiments this invention comprises placing a structural gene for the Bacillus thuringiensis crystal protein under control of a plant or a T-DNA promoter and ahead of a poly-adenylation site followed by insertion of said promoter/structural gene combination into a plant genome by utilizing a Agrobacterium tumefaciens Ti plasmid-based transformation system. The modified Ti plasmid is then used to transform recipient plant cells. Also provided are the plants and tissues produced by this method and bacterial strains, plasmids, and vectors useful for execution of this invention.
Patent NZ-215916-A (NZ)
Title: Enhancing efficacy of phosphate fertiliser by adding scale-inhibiting compound
Inventor: GILL J S
IPC: C05G3/00
Filed: 1986-04-22
Abstract: A method of enhancing the efficacy of a phosphate fertilizer and increasing the availability of other soil nutrients comprises adding to the fertilizer a scale-inhibiting compound. 
<??>An improved fertilizing composition comprises a phosphate fertilizer and a scale-inhibiting compound. 
<??>Preferred scale-inhibiting compounds are 1-hydroxyalkylidene-1,1-diphosponic acid, copolymers of acrylic acid and 2-acrylamido-2-methylpropyl sulphonic acid (AMPS) or 2-meth-acrylamidomethylpropyl sulphonic acid (MAMPS) in which the monomer ratio is in the range 1:50 to 50:1 by weight, copolymers of methacrylic acid and AMPS or MAMPS in which the monomer ratio is 50:1 to 1:50 by weight, copolymers of acrylic acid and a hydroxyalkyl acrylate, copolymers of methacrylic acid and hydroxy alkylacrylate, copolymers of acrylic acid and maleic acid or maleic anhydrides, copolymers of methacrylic acid and maleic acid or maleic anhydrides, and other polymers prepared from acrylic acid, methacrylic acid, maleic acid or maleic anhydride, and hydroxyalkyl acrylates, alone or in combination.
Patent NZ-223088-A (NZ)
Title: Transdermal estrogen/progestin dosage unit
Inventor: CHIEN YIE W
IPC: A61K31/565
Filed: 1988-01-06
Abstract: Transdermal estrogen/progestin absorption dosage units have been developed which comprise a backing layer, an adjoining polymer layer is an adhesive layer in which at least minimum effective dose of an estrogen is dissolved or microdispersed. Adhered to the polymer layer is an adhesive layer in which is dissolved and/or microdispersed at least minimum doses of progestin. Presently preferred is use of the natural estrogen, 17-beta-estradiol, or ethinyl estradiol or combinations thereof and of the progestin, norethindrone or norgestimate or combinations thereof. The units have biologically acceptable adhesive and polymer layers. The adhesive layer can have dispersed one or more skin permeation enhancing agents. A separating layer can optionally be used in making the dosage units, which separate space the adhesive and polymer layers, which permits estrogen transmission from the polymer layer during treatment. Dosage units are provided which transdermally deliver at least minimum daily doses of the estrogen and progestin for multiple days, such as for one week. The invention also provides a process of fertility control and estrogen replacement therapy using the novel dosage units. Also, the invention provides a fertility control system for fertility control using the novel dosage units.
Patent NZ-223669-A (NZ)
Title: Teicoplanin (teichomycin) derivatives and pharmaceutical compositions
Inventor: MALABARBA ADRIANO
IPC: A61P31/04
Filed: 1988-02-26
Abstract: The present invention is directed to teicoplanin derivatives in which position 63 of the glycopeptide core is substituted with a substituted alkylamide.
Patent NZ-225763-A (NZ)
Title: Pyrrolo (2,1-a) isoquinoline derivatives
Inventor: ASHTON MICHAEL JOHN
IPC: C07D471/04
Filed: 1988-08-09
Abstract: Pyrrolo[2,1-a]isoquinoline derivatives of the formula: <CHEM> wherein R<1> and R<2> each represent cycloalkyl or alkyl, alkenyl or alkynyl which may be halogen-substituted, or optionally substituted aryl or heteroaryl, X represents ethylene or vinylene, R<3> represents a group of the formula:    -Y-CH2-CH(OH)-CH2-COOR<5>      II   wherein Y represents carbonyl or hydroxymethylene and R<5> represents hydrogen or optionally substituted alkyl, or R<3> represents a lactone ring, and the symbols R<4> represent hydrogen, halogen, optionally substituted alkyl, alkenyl or alkynyl, optionally substituted aryl or heteroaryl, or a group of the formula R<6>O-, wherein R<6> represents alkyl, aryl or arylalkyl have useful pharmaceutical properties.
Patent NZ-233735-A (NZ)
Title: Heterocyclic substituted aminophenol derivatives
Inventor: BANTICK JOHN RAYMOND
IPC: C07D311/92
Filed: 1990-05-18
Abstract: There are disclosed compounds of the formula (I): , R4, R5, R6, and X are defined in the specification. The compounds are useful as pharmaceuticals, especially as anti-inflammatory agents.
Patent NZ-236893-A (NZ)
Title: Preparation of n-phosphonomethylglycine using fe, zn, al, v, or cu metal or a v, fe or cu salt as decomposition catalyst
Inventor: FIELDS DONALD LEE
IPC: C07B61/00
Filed: 1991-01-24
Abstract: A process is provided for producing N-phosphonomethylglycine by the oxidation of N-phosphonomethyliminodiacetic acid with a peroxide to form an intermediate N-phosphonomethyliminodiacetic acid-N-oxide. Thereafter, the N-phosphonomethyliminodiacetic acid-N-oxide is converted to N-phosphonomethylglycine by adding a catalytic amount of a metal selected from the group consisting of iron, zinc, aluminum, vanadium and copper, or a compound selected from the group consisting of water-soluble vanadium compounds, ferrous salts and cuprous salts.
Patent NZ-240039-A (NZ)
Title: Detergent containing an alkoxy carboxylate salt and a polyhydroxy fatty acid amide
Inventor: FU YI-CHANG
IPC: C11D3/16
Filed: 1991-09-30
Abstract: Disclosed are detergent compositions comprising and alkyl ethoxy carboxylate component and a polyhydroxy fatty acid amide component. The detergent compositions of the present invention possess improved cleaning and sudsing properties and exhibit enhanced mildness to the skin. Also disclosed is a method for cleaning soiled dishes by treating said dishes with the detergent compositions disclosed herein.
Patent NZ-299873-A (NZ)
Title: Tannase covalently immobilised by its glycoside part on an insoluble support; tea extract preparation
Inventor: REYMOND SYLVIANE
IPC: C12N11/00
Filed: 1996-12-04
Abstract: Tannase covalently immobilised by way of its glycosidic part onto an insoluble support is new. Also claimed is a method for the preparation of a tea extract, which comprises preparing an aqueous extract of tea leaves and treating it at 20-65 degrees C with a tannase as above.
Patent NZ-308763-A (NZ)
Title: Production scale method of forming microparticles
Inventor: HERBERT PAUL F
IPC: A61K48/00
Filed: 1996-05-15
Abstract: The present invention relates to a method for forming microparticles of a material from microdroplets of a solution, wherein the solution comprises the material dissolved in a solvent. The method includes the steps of directing the microdroplets into a freezing zone, wherein the freezing zone is surrounded by a liquified gas, and wherein the microdroplets freeze. The frozen microdroplets are then mixed with a liquid non-solvent, whereby the solvent is extracted into the non-solvent, thereby forming the microparticles.
Patent NZ-328353-A (NZ)
Title: Neuraminic acid (5-acetamido-4-guanidino-2,3,4,5,7-pentadeoxy-d-glycero-d-galacto-non-2-enopyranosoic acid) derivatives, pharmaceutical compositions
Inventor: HONDA TAKESHI
IPC: A61K31/351
Filed: 1997-07-16
Abstract: Compounds of formula (I): <CHEM> Äin which R<1> is alkyl or haloalkyl; R<2> and R<3> each represents hydrogen or aliphatic acyl; X is hydroxy, halogen, alkoxy, or a group of formula R<a>O-, where R<a> is aliphatic acyl; Y is a group of formula R<b>R<c>N- or R<b>R<c>N-O-, where R<b> and R<c> each is hydrogen or alkyl; and Z is oxygen or sulphurÜ have excellent sialidase inhibitory activity and are therefore useful for the treatment and prevention of influenza and other viral diseases where the replication of the virus is susceptible to sialidase inhibitors.
Patent NZ-330036-A (NZ)
Title: Electronic multielectrode devices for molecular biology analysis and synthesis
Inventor: HELLER MICHAEL
IPC: C12Q1/6825
Filed: 1994-10-26
Abstract: n electronic device for receiving a solution includes a substrate, and a plurality of selectively addressable electrodes 62 that are disposed on the substrate and electrically insulated from each other prior to receipt of the solution.  A current source provides a selective current for the electrodes, and individual buffer reservoirs 57 are associated with each of the electrodes which are also provided with individual permeation layers disposed adjacent the individual buffer reservoirs, to form addressable binding locations.  Divisional filed as 500373
Patent NZ-333608-A (NZ)
Title: Use of saponin preparations in eliciting or inducing immune responses
Inventor: COX JOHN COOPER
IPC: A61K47/28
Filed: 1995-10-12
Abstract: Preparations of saponins of Quillaja saponaria which comprises an active compound together with one or more pharmaceutically acceptable carrier or diluents characterised by; i. An iscom matrix comprising a saponin preparation comprising saponins of Quillaja saponaria. The preparation comprising 50% to 90% by weight of Fraction A of Quil A and 50% to 10% by weight of Fraction C of Quil A, a sterol and optionally a lipid and at least one immunogen; or ii. An immunogenic iscom which comprises an iscom (immunostimulatory complex) matrix as defined in (i) above, having at least one immunogen incorporated into or associated with the iscom matrix.
Patent NZ-502381-A (NZ)
Title: 3-[1,2,3-triazolo[4,5-d]pyrimidin-3yl]-cyclopentane-1,2,3-triol derivatives useful as P2T antagonists
Inventor: GUILE SIMON
IPC: C07D487/04
Filed: 1998-07-15
Abstract: A 3-[1,2,3-triazolo[4,5-d]pyrimidin-3yl]-cyclopentane derivative or a pharmaceutically acceptable salt or solvate thereof has the formula (I) wherein: R1 is an optionally substituted alkyl, alkenyl, cycloalkyl or a phenyl group; R2 is an optionally substituted alkyl or cycloalkyl group; one of R3 and R4 is hydroxy and the other is hydrogen, hydroxy or NR9R10; R is (CR4R6)mOR7; an optionally substituted alkyl or alkenyl group each of which is already substituted by =S, =O, =NR20 or OR21; m is 0 or 1; R5 and R6 are independently hydrogen or optionally substituted alkyl or phenyl; R7 is hydrogen, alkyl or (CR5R6)nR14; n is 1 to 3; R14 is COOH, OR15, NR16R17 or CONR16R17; R9 and R10 are independently hydrogen or alkyl; R15, R16 and R17 are independently hydrogen or alkyl; R20 is OR24 or NR25R26; R21 is H, alkyl or phenyl and R24 to R26 are as defined in the specification. A pharmaceutical composition thereof useful is for treatment or prevention of myocardial infarction, thrombotic stroke, transient ischaemic attacks, peripheral vascular disease and angina.
Patent NZ-508256-A (NZ)
Title: Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
Inventor: BOHANON MICHAEL JOHN
IPC: A61K31/541
Filed: 1999-05-13
Abstract: The use of an oxazolidinone antibacterial agent and an arginine derivative of formula A in the preparation of a medicament for treating gram-negative organism infections in a mammal, wherein: R1 is optionally substituted aryl or -(CH2)i-aryl, or thienyl, furyl, pyridyl, benzofuranyl, or benzothienyl, Z is R2, or -CHWR2, R2 is optionally substituted aryl or C1-4alkyl, or C1-4alkoxy, C1-4alkylthio, halo, thienyl, furanyl, or pyridyl, W is H, -NH2, C1-4alkylamino, C1-4dialkylamino, halo, hydroxyl, C1-4alkoxy, C1-4alkylthio, or azaheterocycle, i is 0, 1, or 2.
Patent NZ-511389-A (NZ)
Title: Murine expression of human Ig lamda locus
Inventor: BRUGGEMANN MARIANNE
IPC: C12N15/13
Filed: 1999-11-03
Abstract: A transgenic mouse that includes as a translocus a 410Kb YAC which contains most of the human Vl genes of cluster A and all the human Jl-Cl segments in germline configuration, wherein said translocus shows high expression and is able to compete equally with the endogenous mouse k locus.
Patent NZ-511984-A (NZ)
Title: Controlled release formulation comprising GnRH-II
Inventor: QI STEVE
IPC: A61P19/00
Filed: 1999-12-02
Abstract: A pharmaceutical formulation for the controlled release of a therapeutic peptide or a salt thereof, which peptide has the sequence pyroGlu-His-Trp-Ser-Xaa1-Gly-Xaa2-Xaa3-Pro-Gly-NH2 wherein Xaa1 is His or Tyr, ```Xaa2 is Trp or Leu, and ```Xaa3 is Tyr or Arg, provided that when Xaa1 is Tyr and Xaa2 is Leu, then Xaa3 is not Arg, and which formulation further comprises a pharmaceutically acceptable biodegradable polymer preferably a co-polymer of glycolic and lactic acids. The formulation can be used for treating bone and prostate disorders.
Patent NZ-513208-A (NZ)
Title: Topical sprays comprising a film forming composition
Inventor: LULLA AMAR
IPC: A61K9/70
Filed: 2000-02-07
Abstract: A topical, medicinal spray composition comprises one or more medicaments in a volatile vehicle, and one or more film-forming polymers. When sprayed on a topical site, the composition forms a stable, breathable film from which the medicaments are transdermally available. Preferably the composition comprises from about 0.1 % to 30% of one or more medicaments, from about 0.1 % to 15 % film-forming polymer, from about 0.1 % to 10 % solubilizer, from about 0.1 % to 8 % permeation enhancer, from about 1.0 % to 10 % plasticiser, and a vehicle q.s. 100 %. The invention includes a spray dispenser containing the topical composition.
Patent NZ-517806-A (NZ)
Title: Apparatus and process for conditioning mammalian blood
Inventor: MONGOMERY SONYA
IPC: A61M1/36
Filed: 2000-09-15
Abstract: Apparatus (20) is disclosed for conditioning mammalian blood  for  subsequent  use  in  a  medical  procedure.  The apparatus   includes  a  cabinet  (21)   having   a   secure environment  and a door (26) providing the  only  access  to the   environment.   An  input  system   is   provided   for transporting  a  blood charge from a source to  the  cabinet (21)  and a flask (56) is removably contained in the  secure environment  and  coupled  to the  charge  input  system  to receive  the  charge. Stressors (not shown) are  coupled  to the  cabinet (21) and positioned for operation to  create  a conditioned  charge in the flask (56). An output  system  is coupled  to the flask and includes a receiver (52)  for  the conditioned   charge.  The  apparatus   (20)   includes   an automated  control  system operable upon  closing  the  door (26) to lock the door and to then condition the charge,  and to  then  cause  the charge to move from the  flask  to  the receiver.  As  a result, a charge from the input  system  is conditioned and delivered to the receiver, the door is  then unlocked  and the conditioned charge is ready to be  removed and   used  to  complete  the  medical  procedure.  A  flask assembly  (48)  is  also provided for use in  the  apparatus (20) and a process is also described.
Patent NZ-525854-A (NZ)
Title: Lactam compound for inhibiting beta-amyloid and treating Alzheimer's disease
Inventor: AUDIA JAMES EDMUND
IPC: C07D487/02
Filed: 2001-11-05
Abstract: The compound (N)-((S)-2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-(S)-1-amino-3-methyl-4, 5, 6, 7-tetrahydro-2H-3-benzazepin-2-one of formula (I) is described. A pharmaceutical composition comprising the compound is useful for inhibiting b-amyloid peptide release and/or its synthesis and for the treatment, prevention and inhibition of the progression of Alzheimer's disease.
Patent NZ-527372-A (NZ)
Title: Herbal composition for angina pectoris, method to prepare same and uses thereof
Inventor: YAN XIJUN
IPC: A61P25/00
Filed: 2003-08-05
Abstract: A composition comprising the product that when subjected to a separation assay produces 8 peaks as shown in Figure 1, produced by the method comprising steps of: (a) obtaining smashed Radix Salviae Miltorrhizae and Panax Notoginseng; (b) extracting the obtained Radix Salviae Miltorrhizae, Panax Notoginseng in hot aqueous reflux; (c) combining the extracts to form a combined extract; and adding alcohol to concentrate the combined extract to perform alcohol precipitation to obtain a supematant; (d) eliminating the alcohol of the supernatant to obtain a concentrated extract; (e) mixing the concentrated extract from step (d) with appropriate amount of borneol, thereby producing the composition of Radix Salviae Miltorizae, Panax Notoginseng and Bomeol.
Patent NZ-534174-A (NZ)
Title: An isolated human monoclonal antibody which binds to human CD30
Inventor: KELER TIBOR
IPC: C07K16/18
Filed: 2003-01-07
Abstract: Disclosed is an isolated human monoclonal antibody that binds to human CD30. The human antibody can be produced in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are derivatives of the human antibodies (e.g., bispecific antibodies and immunoconjugates), pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent NZ-537741-A (NZ)
Title: Creep resistant magnesium alloy
Inventor: BETTLES COLLEEN JOYCE
IPC: C22F1/00
Filed: 2003-06-20
Abstract: A magnesium based alloy is disclosed, which consists of, by weight: 1.4 - 1.9 % neodymium, 0.8 - 1.2 % rare earth element(s) other than neodymium, 0.4 - 0.7 % zinc, 0.3 - 1 % zirconium, 0 - 0.3 % manganese, and 0 - 0.1 % oxidation inhibiting element(s) the remainder being magnesium except for incidental impurities.